Antileukemic effects of 5- (2-dimethylaminoethoxy) -7-oxo-7H-benzo (c) fluorene, substance VUFB 13 468, on L1210 and la leukemia
Pujman, V.; Cernochová, S.
Neoplasma 28(6): 715-720
1981
ISSN/ISBN: 0028-2685 PMID: 7339500 Document Number: 168532
The antineoplastic effect of 5-(2-dimethyl-aminoethoxy)-7-oxo-7H-benzo(c) fluorene, substance VUFB 13 468, was studied in leukemia L1210 and leukemia La. It was found that the test substance, in the form of base and in the form of hydrochloride, influenced favorably the survival of leukemic mice, in which the life span increased in dependence on the dose and the scheme of its application.
Document emailed within 1 workday
Related Documents
Roubal, Z.; Poláková, L.; Grimová, J.; Kakác, B.; Peterková, M.; Rejholec, V.; Sedlmayer, P.; Janků, I. 1985: Derivatives of benzo(c)fluorene. XVII. Pharmacokinetics of benfluron in animals Ceskoslovenska Farmacie 34(8): 311-313Hrubá, A.; Paluska, E.; Pujman, V.; Polednová, V.; Chudomel, V.; Krepelka, J. 1984: Derivatives of benzo(c)fluorene. XI. Effect of Benfluron on hemopoietic stem cells Neoplasma 31(4): 407-413
Veselá, J.; Drsata, J. 1988: The effect of 5-[2-(N,N-dimethylamino)ethoxy]-7-oxo-7H-benzo(c) fluorene hydrochloride (Benfluron, a cytostatic) on ornithine decarboxylase activity in the regenerating rat liver in vivo Ceskoslovenska Farmacie 37(6): 251-254
Himori, T.; Sugawara, N. 1972: Evaluation of antileukemic agents using transplantable rat leukemia induced by nitrosobutylurea (NBU) (DBLA-lines) as a screening tool: method of treatment of leukemia based on the results in experimental leukemia Nihon Rinsho. Japanese Journal of Clinical Medicine 30(4): 1051-1061
Votava, Z.; Metys, J.; Dlabac, A. 1975: The EEG effects of VUFB-10.032, clozapine and octoclothepin in rabbits Activitas Nervosa Superior 17(4): 216
Faderl, S.; Ferrajoli, A.; Harris, D.; Van, Q.; Priebe, W.; Estrov, Z. 2005: WP-1034, a novel JAK-STAT inhibitor, with proapoptotic and antileukemic activity in acute myeloid leukemia (AML) Anticancer Research 25(3b): 1841-1850
Misíková, Z.; Lehotská, V. 1980: Urinary system functions in children with intensive antileukemic therapy of acute lymphoblastic leukemia Neoplasma 27(4): 489-492
Sedlmayer, P.; Sispera, L.; Rejholec, V.; Chaura, Z. 1984: Biological availability and pharmacological effects of Prazosin VUFB in dogs Ceskoslovenska Farmacie 33(6): 235-237
Pasternak, G. 1972: Influence of heterologous antileukemic rabbit immune sera on the growth of transplantable leukemia in the XVII-Bln mouse strain Archiv für Geschwulstforschung 39(1): 40-43
Manabe, A.; Yi, T.; Kumagai, M.; Campana, D. 1993: Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. I. Cytotoxicity of interferon alpha in acute lymphoblastic leukemia Leukemia 7(12): 1990-1995
Kumagai, M.; Manabe, A.; Coustan-Smith, E.; Blakley, R.L.; Beck, W.T.; Santana, V.M.; Behm, F.G.; Raimondi, S.C.; Campana, D. 1994: Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. II. Potent cytotoxicity of 2-chloro-deoxyadenosine in acute lymphoblastic leukemia Leukemia 8(7): 1116-1123
Shen, A.L.; Fahl, W.E.; Wrighton, S.A.; Jefcoate, C.R. 1979: Inhibition of benzo(a)pyrene and benzo(a)pyrene 7,8-dihydrodiol metabolism by benzo(a)pyrene quinones Cancer Research 39(10): 4123-4129
Wood, A.W.; Wislocki, P.G.; Chang, R.L.; Levin, W.; Lu, A.Y.; Yagi, J.; Hernandez, O.; Herina, D.M.; Conney, A.H. 1976: Mutagenicity and cytotoxicity of benzo(a)pyrene benzo-ring epoxides Cancer Research 36(9 Pt.1): 3358-3366
Hu, X.; Xia, H.; Srivastava, S.K.; Pal, A.; Awasthi, Y.C.; Zimniak, P.; Singh, S.V. 1998: Catalytic efficiencies of allelic variants of human glutathione S-transferase P1-1 toward carcinogenic anti-diol epoxides of benzo[c]phenanthrene and benzo[g]chrysene Cancer Research 58(23): 5340-5343
Falkenhein, S.F.; Macdonald, H.; Huber, M.M.; Koch, D.; Parker, C.W. 1980: Effect of the 5-hydroperoxide of eicosatetraenoic acid and inhibitors of the lipoxygenase pathway on the formation of slow reacting substance by rat basophilic leukemia cells; direct evidence that slow reacting substance is a product of the lipoxygenase pathway Journal of Immunology 125(1): 163-168
Uchida, S.; Honda, F.; Otsuka, M.; Satoh, Y.; Mori, J.; Ono, T.; Hitomi, M. 1979: Pharmacological study of [2-chloro-11-(2-dimethylaminoethoxy) dibenzo[b,f]thiepine] (zotepine), a new neuroleptic drug Arzneimittel-Forschung 29(10): 1588-1594
Fousteris, M.A.; Koutsourea, A.I.; Arsenou, E.S.; Papageorgiou, A.; Mourelato, D.; Nikolaropoulos, S.S. 2002: Antileukemic and cytogenetic effects of modified and non-modified esteric steroidal derivatives of 4-methyl-3-bis(2-chloroethyl)amino benzoic acid (4-Me-CABA) Anticancer Research 22(4): 2293-2299
MacLeod, M.C.; Cohen, G.M.; Selkirk, J.K. 1979: Metabolism and macromolecular binding of the carcinogen benzo(a)pyrene and its relatively inert isomer benzo(e)pyrene by hamster embryo cells Cancer Research 39(9): 3463-3470
Jiang, Y.; Chen, J.; Chen, X. 2001: Malignant transformation of human bronchial epithelial cells induced by benzo(a)pyrene metabolite dihydroxyepoxy benzo pyrene Wei Sheng Yan Jiu 30(3): 129-131
Harris, C.C.; Kaufman, D.G.; Sporn, M.B.; Boren, H.; Jackson, F.; Smith, J.M.; Pauley, J.; Dedick, P.; Saffiotti, U. 1973: Localization of benzo(a)pyrene-3H and alterations in nuclear chromatin caused by benzo(a)pyrene-ferric oxide in the hamster respiratory epithelium Cancer Research 33(11): 2842-2848